Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology - PubMed (original) (raw)
Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology
Shinjiro Fukami et al. Neurosci Res. 2002 May.
Abstract
Metabolism of amyloid-beta peptide (Abeta) is closely associated with the pathology and etiology of Alzheimer's disease (AD). Since neprilysin is the only rate-limiting catabolic peptidase proven by reverse genetics to participate in Abeta metabolism in vivo, we performed detailed immunohistochemical analysis of neprilysin in mouse brain using neprilysin-deficient mice as a negative control. The aim was to assess, at both the cellular and subcellular levels, where Abeta undergoes neprilysin-dependent degradation in the brain and how neprilysin localization relates to Abeta pathology in amyloid precursor protein (APP)-transgenic mice. In hippocampus, neprilysin was present in the stratum pyramidale and stratum lacunosum-moleculare of the CA1-3 fields and the molecular layer of the dentate gyrus. Confocal double immunofluorescence analyses revealed the subcellular localization of neprilysin along axons and at synapses. This observation suggests that after synthesis in the soma, neprilysin, a type II membrane-associated protein, is axonally transported to the terminals, where Abeta degradation is likely to take place. Among various cell types, GABAergic and metabotropic glutamate 2/3 receptor-positive neurons but not catecholaminergic or cholinergic neurons, expressed neprilysin in hippocampus and neocortex, implying the presence of a cell type-specific mechanism that regulates neprilysin gene expression. As expected, Abeta deposition correlated inversely with neprilysin expression in TgCRND8 APP-transgenic mice. These observations not only support the notion that neprilysin functions as a major Abeta-degrading enzyme in the brain but also suggest that down-regulation of neprilysin activity, which may be caused by aging, is likely to elevate local concentrations of Abeta at and around neuronal synapses.
Similar articles
- Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC. Iwata N, et al. J Neurosci Res. 2002 Nov 1;70(3):493-500. doi: 10.1002/jnr.10390. J Neurosci Res. 2002. PMID: 12391610 - Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, Cheng IH, Yu GQ, Mucke L. Meilandt WJ, et al. J Neurosci. 2009 Feb 18;29(7):1977-86. doi: 10.1523/JNEUROSCI.2984-08.2009. J Neurosci. 2009. PMID: 19228952 Free PMC article. - Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.
Iwata N, Mizukami H, Shirotani K, Takaki Y, Muramatsu S, Lu B, Gerard NP, Gerard C, Ozawa K, Saido TC. Iwata N, et al. J Neurosci. 2004 Jan 28;24(4):991-8. doi: 10.1523/JNEUROSCI.4792-03.2004. J Neurosci. 2004. PMID: 14749444 Free PMC article. - Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
Higuchi M, Iwata N, Saido TC. Higuchi M, et al. Biochim Biophys Acta. 2005 Aug 1;1751(1):60-7. doi: 10.1016/j.bbapap.2005.02.013. Epub 2005 Mar 17. Biochim Biophys Acta. 2005. PMID: 16054018 Review. - [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M, Kawakubo T, Mori R, Iwata N. Asai M, et al. Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
Cited by
- Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice.
Sandoval K, Umbaugh D, House A, Crider A, Witt K. Sandoval K, et al. Neurochem Res. 2019 Nov;44(11):2670-2680. doi: 10.1007/s11064-019-02890-6. Epub 2019 Oct 19. Neurochem Res. 2019. PMID: 31630317 Free PMC article. - Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.
Tampellini D, Gouras GK. Tampellini D, et al. Front Aging Neurosci. 2010 May 21;2:13. doi: 10.3389/fnagi.2010.00013. eCollection 2010. Front Aging Neurosci. 2010. PMID: 20725518 Free PMC article. - Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.
Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Khalifa AA, Saad HM, Batiha GE. Ali NH, et al. J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17. J Cell Mol Med. 2024. PMID: 37847125 Free PMC article. Review. - Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer's disease pathogenesis.
Civitelli L, Marcocci ME, Celestino I, Piacentini R, Garaci E, Grassi C, De Chiara G, Palamara AT. Civitelli L, et al. J Neurovirol. 2015 Oct;21(5):480-90. doi: 10.1007/s13365-015-0344-0. Epub 2015 Apr 30. J Neurovirol. 2015. PMID: 25925093 - Caspase Inhibition Restores NEP Expression and Rescues Olfactory Deficit in Rats Caused by Prenatal Hypoxia.
Vasilev D, Dubrovskaya NM, Nalivaeva NN. Vasilev D, et al. J Mol Neurosci. 2022 Jul;72(7):1516-1526. doi: 10.1007/s12031-022-01986-z. Epub 2022 Mar 28. J Mol Neurosci. 2022. PMID: 35344141
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous